Helena Andreu , Kamilla Woznica Miskowiak , Julian Macoveanu , Lars Vedel Kessing , Eduard Vieta , Gitte Moos Knudsen , Vibe G. Frokjaer , Anjali Sankar
{"title":"情绪障碍患者既往自杀企图与腹内侧前额叶皮质体积减少和注意力受损有关。","authors":"Helena Andreu , Kamilla Woznica Miskowiak , Julian Macoveanu , Lars Vedel Kessing , Eduard Vieta , Gitte Moos Knudsen , Vibe G. Frokjaer , Anjali Sankar","doi":"10.1016/j.jpsychires.2025.09.040","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Patients with mood disorders, including bipolar disorder (BD) and major depressive disorder (MDD) are at heightened risk of suicidal behavior. Therefore, there is an urgent need for biomarkers to enable enhanced prevention approaches in high-risk individuals. Among potential biomarkers, brain structural measures and cognitive function are particularly promising.</div></div><div><h3>Objectives</h3><div>This study aims to replicate the role of ventromedial prefrontal cortex (vmPFC) in suicidal behavior across patients with mood disorders (MD) and to examine cognitive domains that may be impaired in this population.</div></div><div><h3>Methods</h3><div>Data on prior suicide attempts (SA) were obtained from the Danish Registers in a sample of 307 patients with MD who had magnetic resonance imaging (MRI) data (22 patients with MD and SA [MD<sub>SA</sub>], 285 patients with MD and no SA [MD<sub>NSA</sub>]) and an overlapping sample of 489 patients with neurocognitive assessments (31 MD<sub>SA</sub>, 458 MD<sub>NSA</sub>).</div></div><div><h3>Results</h3><div>MD<sub>SA</sub> showed lower vmPFC volume compared to MD<sub>NSA</sub> (p = 0.04). Secondarily, it was found that MD<sub>SA</sub> show greater attention deficits in comparison with MD<sub>NSA</sub> (p = 0.03), with no significant differences in the other neurocognitive functions.</div></div><div><h3>Conclusions</h3><div>Reduced vmPFC volume and deficits in attention may be associated with history of suicidal behaviors in patients with MD. These findings support previous research highlighting the role of vmPFC in suicidal behavior and suggest that there may be specific cognitive subdomains that are particularly affected, offering potential intervention targets for future evaluation.</div></div>","PeriodicalId":16868,"journal":{"name":"Journal of psychiatric research","volume":"191 ","pages":"Pages 501-506"},"PeriodicalIF":3.2000,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Reduced ventromedial prefrontal cortex volume and impaired attention associated with past suicide attempts in patients with mood disorders\",\"authors\":\"Helena Andreu , Kamilla Woznica Miskowiak , Julian Macoveanu , Lars Vedel Kessing , Eduard Vieta , Gitte Moos Knudsen , Vibe G. Frokjaer , Anjali Sankar\",\"doi\":\"10.1016/j.jpsychires.2025.09.040\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><div>Patients with mood disorders, including bipolar disorder (BD) and major depressive disorder (MDD) are at heightened risk of suicidal behavior. Therefore, there is an urgent need for biomarkers to enable enhanced prevention approaches in high-risk individuals. Among potential biomarkers, brain structural measures and cognitive function are particularly promising.</div></div><div><h3>Objectives</h3><div>This study aims to replicate the role of ventromedial prefrontal cortex (vmPFC) in suicidal behavior across patients with mood disorders (MD) and to examine cognitive domains that may be impaired in this population.</div></div><div><h3>Methods</h3><div>Data on prior suicide attempts (SA) were obtained from the Danish Registers in a sample of 307 patients with MD who had magnetic resonance imaging (MRI) data (22 patients with MD and SA [MD<sub>SA</sub>], 285 patients with MD and no SA [MD<sub>NSA</sub>]) and an overlapping sample of 489 patients with neurocognitive assessments (31 MD<sub>SA</sub>, 458 MD<sub>NSA</sub>).</div></div><div><h3>Results</h3><div>MD<sub>SA</sub> showed lower vmPFC volume compared to MD<sub>NSA</sub> (p = 0.04). Secondarily, it was found that MD<sub>SA</sub> show greater attention deficits in comparison with MD<sub>NSA</sub> (p = 0.03), with no significant differences in the other neurocognitive functions.</div></div><div><h3>Conclusions</h3><div>Reduced vmPFC volume and deficits in attention may be associated with history of suicidal behaviors in patients with MD. These findings support previous research highlighting the role of vmPFC in suicidal behavior and suggest that there may be specific cognitive subdomains that are particularly affected, offering potential intervention targets for future evaluation.</div></div>\",\"PeriodicalId\":16868,\"journal\":{\"name\":\"Journal of psychiatric research\",\"volume\":\"191 \",\"pages\":\"Pages 501-506\"},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2025-09-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of psychiatric research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S002239562500562X\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of psychiatric research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S002239562500562X","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
Reduced ventromedial prefrontal cortex volume and impaired attention associated with past suicide attempts in patients with mood disorders
Introduction
Patients with mood disorders, including bipolar disorder (BD) and major depressive disorder (MDD) are at heightened risk of suicidal behavior. Therefore, there is an urgent need for biomarkers to enable enhanced prevention approaches in high-risk individuals. Among potential biomarkers, brain structural measures and cognitive function are particularly promising.
Objectives
This study aims to replicate the role of ventromedial prefrontal cortex (vmPFC) in suicidal behavior across patients with mood disorders (MD) and to examine cognitive domains that may be impaired in this population.
Methods
Data on prior suicide attempts (SA) were obtained from the Danish Registers in a sample of 307 patients with MD who had magnetic resonance imaging (MRI) data (22 patients with MD and SA [MDSA], 285 patients with MD and no SA [MDNSA]) and an overlapping sample of 489 patients with neurocognitive assessments (31 MDSA, 458 MDNSA).
Results
MDSA showed lower vmPFC volume compared to MDNSA (p = 0.04). Secondarily, it was found that MDSA show greater attention deficits in comparison with MDNSA (p = 0.03), with no significant differences in the other neurocognitive functions.
Conclusions
Reduced vmPFC volume and deficits in attention may be associated with history of suicidal behaviors in patients with MD. These findings support previous research highlighting the role of vmPFC in suicidal behavior and suggest that there may be specific cognitive subdomains that are particularly affected, offering potential intervention targets for future evaluation.
期刊介绍:
Founded in 1961 to report on the latest work in psychiatry and cognate disciplines, the Journal of Psychiatric Research is dedicated to innovative and timely studies of four important areas of research:
(1) clinical studies of all disciplines relating to psychiatric illness, as well as normal human behaviour, including biochemical, physiological, genetic, environmental, social, psychological and epidemiological factors;
(2) basic studies pertaining to psychiatry in such fields as neuropsychopharmacology, neuroendocrinology, electrophysiology, genetics, experimental psychology and epidemiology;
(3) the growing application of clinical laboratory techniques in psychiatry, including imagery and spectroscopy of the brain, molecular biology and computer sciences;